Back to Stakeholders
Care Delivery & Psychedelic FacilitationClinical Care Delivery OrganizationsHealth Systems & Hospitals
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchIndependent Academic Research Groups
Care Delivery & Psychedelic FacilitationClinical Care Delivery Organizations
Care Delivery & Psychedelic Facilitation
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & Manufacturing

Herzog Hospital

Israel
1 Trial

Herzog Hospital is Israel's oldest psychiatric institution (est. 1894), operating 550 beds in Jerusalem and home to the country's only dedicated inpatient unit for severe treatment-resistant depression. Researcher Dr. Uriel Heresco-Levy leads investigation of novel psilocybin combinations with NMDAR modulators for depression, including a joint patent with Hadassah BrainLabs (PCT WO 2024/052895 A1).

Academic Research

0 papers

Published Papers

0

Trial Involvement

1

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
Non-Profit
HQ
Israel
Website
Visit

Sponsored Trials

1
RecruitingIII

Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural Reactivity Mechanisms in Veterans With PTSD and Moral Injury

Start Date
Compounds
MDMA